The expression of Piezo2 in the colon significantly correlated to visceral sensitivity in PI-IBS model mice, indicating Piezo2 might act as a candidate biomarker for visceral hypersensitivity in IBS (13). Here, PIEZO2 is linked to irritable bowel syndrome.